Announcement of guarantee

release time:

2024-01-09 16:07

AnnouncementNumber: 2024-003

Stock code: 832316                      Securities abbreviation: Tim Zheng Biotech                 Host brokerage: Shenwan Hongyuan underwriting sponsor

 

Jilin Tianzheng Biotechnology Co., Ltd

Announcement of guarantee

 

The Company and all members of the Board of Directors warrant that the content of the announcement is true, accurate and complete, and there are no false records, misleading statements or material omissions, and assume individual and joint legal responsibility for the authenticity, accuracy and completeness of its content.

 

1. Overview of the guarantee situation
(1) Basic situation of guarantee
Hunchun Deren Pharmaceutical Co., LTD., a wholly-owned subsidiary of the company, intends to sign a loan contract with Industrial Bank Co., LTD. Jilin Branch. The loan amount is expected to be no more than RMB 5 million and the loan term is no more than one year. The hospital receivables are used as the source of repayment, and Jilin Tianzheng Biotechnology Co., Ltd. provides guarantee for it (the specific guarantee is subject to the contract signed).
(2) Whether it constitutes an affiliated transaction
This transaction does not constitute an affiliated transaction.
(3) Review and voting
On January 5, 2024, the Company held the second meeting of the fourth Board of Directors to consider and pass the Motion on the Company's Guarantee for the loan of a wholly-owned subsidiary Bank, with the voting result being: 5 votes in agreement, 0 votes against, and 0 abstentions. Avoidance of voting: None.
In accordance with the Articles of Association, this motion does not need to be submitted to the General meeting for consideration.

 

2. Basic information of the guaranteed
(1) Legal persons and other economic organizations
1. Basic information of the guaranteed
Name: Hunchun Deren Pharmaceutical Co., LTD
Date of establishment: 5 March 2004
Address: Store No. 1.2.3.4, Building 117, Huanyashancheng Community, Jinghe Street, Hunchun City, Yanbian Prefecture, Jilin Province
Registered address: Store No. 1.2.3.4, Building 117, Huanyashancheng Community, Jinghe Street, Hunchun City, Yanbian Prefecture, Jilin Province
Registered capital: RMB 6,000,000
Main business: Wholesale: proprietary Chinese medicine, chemical pharmaceutical preparations, antibiotics, Chinese herbal decoction pieces, biological products (except vaccines), protein assimilation preparations, peptide hormones, health food, medical equipment, medical disinfectant, medical supplies and equipment, disinfection supplies, food, daily necessities, household appliances, cosmetics, hygiene products; Medicine and medical consulting services; Import and export trade permitted by laws and regulations. (For projects subject to approval according to law, business activities can only be carried out after approval by relevant departments)
Legal representative: CAI Timing
Controlling shareholder: Jilin Tianzheng Biotechnology Co., LTD
Actual controller: Jilin Tianzheng Biotechnology Co., LTD
Whether it is the controlling shareholder, the actual controller or its affiliates: No
Whether a counterguarantee is provided: No
Relation: The guarantee is a wholly-owned subsidiary of the company
2. Credit status of the guaranteed
Credit status: not the person who is executed for breach of trust
Total assets as of June 30, 2023: $31,815,447.76
Total current liabilities as of June 30, 2023:10,801,642.21 yuan
June 30, 2023 Net worth: $21,013,805.5
June 30, 2023 asset-liability ratio: 33.95%
June 30, 2023 asset-liability ratio: 33.95%
Revenue for June 30, 2023:20,744,989.44 yuan
Total profit on June 30, 2023: $1,699,802.14
June 30, 2023 Net profit: 1,614,812.03 yuan
Audit Status: Unaudited financial data as at 30 June 2023.

 

3. Main contents of the guarantee agreement
Hunchun Deren Pharmaceutical Co., LTD., a wholly-owned subsidiary of the company, intends to sign a loan contract with Industrial Bank Co., LTD. Jilin Branch. The loan amount is expected to be no more than RMB 5 million and the loan term is no more than one year. The hospital receivables are used as the source of repayment, and Jilin Tianzheng Biotechnology Co., Ltd. provides guarantee for it (the specific guarantee is subject to the contract signed).

 

4. Opinions of the Board of Directors
(1) Reasons for guarantee
Provide guarantees for wholly-owned subsidiaries as required by business development.
(2) The benefits and risks of the guarantee matters
The guarantee will not bring significant financial risks to the company and the guarantee risks are controllable.
(3) Impact on the company
This guarantee will not adversely affect the production and business activities of the company, and will not harm the interests of the company and all shareholders.

 

5. Information on the cumulative provision of guarantees

Project Amount / 10,000 Yuan The proportion of the company's audited net assets in the latest period
The balance guaranteed by the listed company and its holding subsidiaries to entities outside the consolidated statements of the listed company - -
The balance of guarantee of the listed company to the holding subsidiary 500 1.50%
A guaranteed balance exceeding 50% of its most recent audited net assets - -
The balance of the guarantee provided to the guarantee object whose asset-liability ratio exceeds 70% - -
The secured balance of the overdue debt - -
The amount of security involved in the action - -
The amount of security to be assumed as a result of a judgment against the security - -

 

6. File directory for reference
Resolution of the Second Meeting of the Fourth Board of Directors of Jilin Tianzheng Biotechnology Co., LTD.

 

 

 

Jilin Tianzheng Biotechnology Co., LTD
Board of directors
January 5, 2024